Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’
07 déc. 2017 08h45 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm. Included in this...